Kunal
Nepali
a,
Sunil
Kumar
a,
Hsiang-Ling
Huang
a,
Fei-Chiao
Kuo
a,
Cheng-Hsin
Lee
a,
Ching-Chuan
Kuo
b,
Teng-Kuang
Yeh
b,
Yu-Hsuan
Li
a,
Jang-Yang
Chang
c,
Jing-Ping
Liou
a and
Hsueh-Yun
Lee
*a
aSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan. E-mail: hyl@tmu.edu.tw; Tel: +886-2-27361661 ext 6134
bInstitute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan
cNational Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan
First published on 15th June 2018
Correction for ‘2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition’ by Kunal Nepali et al., Org. Biomol. Chem., 2016, 14, 716–723.
In addition, in the experimental details for compound 15 a singlet peak at δ 2.36 (s, 6H) was omitted.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2018 |